Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study
WebcastFaculty
OVERVIEW
Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study is organized by Heart Rhythm Society (HRS) and would be held during Aug 31, 2017 - Sep 05, 2018.
Target Audience:
• Physician
• Nurse/Allied Professional
• Electrophysiology Fellow
• Cardiology Fellow
Description:
Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study
The subcutaneous ICD (S-ICD) was developed to reduce short and long-term complications associated with transvenous ICD leads. Early studies in the US and Europe were enriched with younger patients with less left ventricular systolic dysfunction and fewer comorbidities than transvenous ICD subjects, making comparisons between systems difficult. Following FDA approval in 2012 a prospective registry of the S-ICD was undertaken, which is the largest study of this device to date.
Pre-implantation patients were enrolled if they met criteria for ICD, passed at least one vector in ECG screening and had a life expectancy > 1 year. Implant technique, programming and conversion testing were performed using the standard of care of investigational centers. Results were analyzed with descriptive statistics, Kaplan Meier time to event analysis, and multivariate logistic regression.
Additional details will be posted as soon as they are available.
Target Audience:
• Physician
• Nurse/Allied Professional
• Electrophysiology Fellow
• Cardiology Fellow
Description:
Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study
The subcutaneous ICD (S-ICD) was developed to reduce short and long-term complications associated with transvenous ICD leads. Early studies in the US and Europe were enriched with younger patients with less left ventricular systolic dysfunction and fewer comorbidities than transvenous ICD subjects, making comparisons between systems difficult. Following FDA approval in 2012 a prospective registry of the S-ICD was undertaken, which is the largest study of this device to date.
Pre-implantation patients were enrolled if they met criteria for ICD, passed at least one vector in ECG screening and had a life expectancy > 1 year. Implant technique, programming and conversion testing were performed using the standard of care of investigational centers. Results were analyzed with descriptive statistics, Kaplan Meier time to event analysis, and multivariate logistic regression.
Additional details will be posted as soon as they are available.
SPECIALITIES
CardiologyClinical Cardiac ElectrophysiologyRELATED ONLINE COURSES
Quick Links